AzTrials
AzTrials

Healthy Gut MicrobiotaNCT03595306

Human Gut Microbiota and Prebiotic Response

A study testing Prebiotic A - inulin, Prebiotic B - galactooligosaccharides(GOS) and Prebiotic C - wheat dextrin in people with Healthy Gut Microbiota, run by Duke University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is designed to examine the shift in gut microbiota and their metabolism after consumption of a dietary supplement (prebiotic) by healthy participants. The investigators will provide participants with a panel of over the counter prebiotics and monitor their gut microbiome response in stool. Read more about this study

Who is it for?
Ages 17 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Healthy Gut Microbiota
What is being tested?
Prebiotic A - inulin, Prebiotic B - galactooligosaccharides(GOS) and Prebiotic C - wheat dextrin
Could I receive a placebo?
No, everyone receives an active treatment
How many people
41 participants
Where
1 siteUnited States
Study dates
1 May 2018to 19 May 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 17 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Provide Stool Samples at no risk to yourself

Who cannot join

  • No oral antibiotic treatments within previous 1 month
  • No known allergy to milk products or lactose intolerance
  • no known allergy to wheat or gluten intolerance
  • no history of irritable bowel syndrome
  • no history of inflammatory bowel disease
  • no history of type-2 diabetes
Show all 10Show fewer
  • no history of chronic kidney disease or reduced kidney function
  • no current intestinal obstructions
  • no current untreated colorectal cancer
  • not currently pregnant or breastfeeding

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Duke University

    Durham, North Carolina, 27708

Other trials in United States

About this study

This study is designed to examine the shift in gut microbiota and their metabolism after consumption of a dietary supplement (prebiotic) by healthy participants. The investigators will provide participants with a panel of over the counter prebiotics and monitor their gut microbiome response in stool. All prebiotics will be commercially available, over-the-counter food, food additives, or dietary supplements, without any known market-use adverse effects beyond minimal discomfort.

Being tested
Prebiotic A - inulin, Prebiotic B - galactooligosaccharides(GOS), Prebiotic C - wheat dextrin

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Prebiotic A - inulinDietary supplement

    Pre-weighed packages will be given twice daily for 5 days.

  • Prebiotic B - galactooligosaccharides(GOS)Dietary supplement

    Pre-weighed packages will be given twice daily for 5 days.

  • Prebiotic C - wheat dextrinDietary supplement

    Pre-weighed packages will be given twice daily for 5 days.

Study groups in NCT03595306
Study groupRoleWhat they receive
Prebiotic AExperimentalNot described
Receives: Dietary Supplement: Prebiotic A - inulin; Dietary Supplement: Prebiotic B - galactooligosaccharides(GOS); Dietary Supplement: Prebiotic C - wheat dextrin
Prebiotic BExperimentalNot described
Receives: Dietary Supplement: Prebiotic A - inulin; Dietary Supplement: Prebiotic B - galactooligosaccharides(GOS); Dietary Supplement: Prebiotic C - wheat dextrin
Prebiotic CExperimentalNot described
Receives: Dietary Supplement: Prebiotic A - inulin; Dietary Supplement: Prebiotic B - galactooligosaccharides(GOS); Dietary Supplement: Prebiotic C - wheat dextrin

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change in levels of SCFAs in stool samples

    Measured: Baseline and 6 weeks

Secondary outcomes (1)
  1. change in levels of cytokines in stool samples

    Measured: Baseline and 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jul 2018
  2. Study start1 May 2018
  3. Primary completion19 May 2019
  4. Study completion19 May 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
41 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03595306
Sponsor's protocol ID
Pro00087214
Status last verified
May 2019
First submitted
11 Jul 2018
Last updated
3 Jun 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Prebiotic A - inulin, Prebiotic B - galactooligosaccharides(GOS) and Prebiotic C - wheat dextrin in people with Healthy Gut Microbiota, run by Duke University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Jun 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change in levels of SCFAs in stool samples (time frame: Baseline and 6 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2019; AzTrials last refreshed its copy on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in